FDA guidance

VanNaarden
Biotech

Lilly oncology head weighs in on FDA cancer drug policies

Lilly’s oncology chief, Jake Van Naarden, suggested that the FDA's policies on clinical trial crossover and high U.S. enrollment are not compatible.
Angus Liu Oct 21, 2025 11:53am
Globe

FDA issues draft guidance for global cancer clinical trials

Sep 23, 2024 1:00pm
alzheimers brain neurodegenerative memory head

FDA revises guidance on predicting Alzheimer's drug benefits

Mar 12, 2024 7:40am
Gene editing gene therapy CRISPR

FDA gene editing guidance 'benign' but still important: analysts

Mar 16, 2022 10:55am
FDA

FDA calls on companies to be 'recall ready'

Mar 7, 2022 11:40am
FDA Building 2

FDA tightens regulations for surgical staplers and staples

Oct 7, 2021 4:55pm